Evidence map›Paper›PMID 28657510›Full record

ArticleThyroid : official journal of the American Thyroid Association2017

Results of Screening in Familial Non-Medullary Thyroid Cancer.

Joanna Klubo-Gwiezdzinska, Lily Yang, Roxanne Merkel, Dhaval Patel, Naris Nilubol, Maria J Merino, Monica Skarulis, Samira M Sadowski, Electron Kebebew

Open access · greenAbstract read
In one paragraph

Article in Thyroid : official journal of the American Thyroid Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Guideline
  4. Article
  5. Article
  6. Hereditary Endocrine Tumor Registries.Journal of the Endocrine Society · 2023
    Article
  7. Epidemiology of Thyroid Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  8. Genetic susceptibility to hereditary non-medullary thyroid cancer.Hereditary cancer in clinical practice · 2022
    Review
  9. Article
  10. Article
  11. Familial non-medullary thyroid cancer: a critical review.Journal of endocrinological investigation · 2021
    Review
  12. Article
  13. Review
  14. Article
  15. BROX haploinsufficiency in familial nonmedullary thyroid cancer.Journal of endocrinological investigation · 2021
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Joanna Klubo-Gwiezdzinska1 Diabetes, Obesity and Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute, National Institutes of Health , Bethesda, Maryland.
Lily Yang2 Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health , Bethesda, Maryland.
Roxanne Merkel2 Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health , Bethesda, Maryland.
Dhaval Patel2 Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health , Bethesda, Maryland.
Naris Nilubol2 Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health , Bethesda, Maryland.
Maria J Merino3 Laboratory of Pathology, National Cancer Institute, National Institutes of Health , Bethesda, Maryland.
Monica Skarulis1 Diabetes, Obesity and Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute, National Institutes of Health , Bethesda, Maryland.
Samira M Sadowski2 Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health , Bethesda, Maryland.
Electron Kebebew2 Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health , Bethesda, Maryland.
National Cancer Institute · USNational Institutes of Health · USUniversity Hospital of Geneva · CH

Funding

Clinical and genetic studies in familial nonmedullary thyroid cancer (FNMTC)ZIABC011287 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KEBEBEW, ELECTRON · 2010 to 2018
$3.4M
Studies of Benign and Malignant Thyroid DiseaseZIEDK047053 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI KLUBO-GWIEZDZINSKA, JOANNA · 2013 to 2020
$1.9M
6 · The paper itself

Abstract

backgroundAlthough a family history of thyroid cancer is one of the main risk factors for thyroid cancer, the benefit of screening individuals with a family history of thyroid cancer is not known.

methodsA prospective cohort study was performed with yearly screening using neck ultrasound and fine-needle aspiration biopsy of thyroid nodule(s) >0.5 cm in at-risk individuals whose relatives were diagnosed with familial non-medullary thyroid cancer (FNMTC). The eligibility criteria were the presence of thyroid cancer in two or more first-degree relatives and being older than seven years of age. Twenty-five kindred were enrolled in the study (12 families with two members affected, and 13 with three or more members affected at enrollment).

resultsThyroid cancer was detected by screening in 4.6% (2/43) of at-risk individuals from families with two members affected, and in 22.7% (15/66) of at-risk members from families with three or more patients affected (p = 0.01). FNMTC detected by screening was characterized by a smaller tumor size (0.7 ± 0.5 cm vs. 1.5 ± 1.1 cm; p = 0.006), a lower rate of central neck lymph node metastases (17.6% vs. 51.1%; p = 0.02), less extensive surgery (hemithyroidectomy 23.5% vs. 0%; p = 0.002), and a lower rate of radioactive iodine therapy (23.5% vs. 79%; p < 0.001) compared to those affected at enrollment.

conclusionsScreening of at-risk family members resulted in earlier detection of low-risk FNMTC and was associated with a less aggressive initial treatment. Screening with thyroid ultrasound should be considered in kindred with three or more family members affected by FNMTC. Since active screening might be associated with the risk of overtreatment, it should be implemented with caution, specifically in elderly individuals.

Indexed as

Family HealthMass ScreeningAdolescentAdultAgedAge FactorsBiopsy, Fine-NeedleCarcinoma, PapillaryChildCohort StudiesEarly Detection of CancerFollow-Up StudiesHumansIncidenceMiddle AgedNational Institutes of Health (U.S.)familialscreeningthyroid cancerthyroidectomyultrasound

Identifiers

PMID28657510
PMCPMC5564020
OpenAlexW2730025597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.